Back to results
US 2006/0142210 A1Published application
Glucopyranosyl-substituted benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
AssigneeBoehringer Ingelheim International GmbH
InventorsMatthias Eckhardt, Frank Himmelsbach, Peter Eickelmann, Leo Thomas, Edward Barsoumian
Life of this patent
Estimating the term…
Abstract
Glucopyranosyl-substituted benzene derivatives defined according to claim 1, including the tautomers, the stereoisomers thereof, the mixtures thereof and the salts thereof. The compounds according to the invention are suitable for the treatment of metabolic disorders.
Claims11
A glucopyranosyl-substituted benzene derivative selected from among:
- (1) 1-Methyl-2-(4-cyclopentyloxy-benzyl)-4-(β-D-glucopyranos1-yl)-benzene,
- (2) 1-Methyl-2-[4-((R)-tetrahydrofuran-3-yloxy)-benzyl]-4-(β-D-glucopyranos-1-yl)-benzene,
- (3) 1-Methyl-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-4-(β-D-glucopyranos-1-yl)-benzene,
- (4) 1-Methyl-2-(4-cyclohexyloxy-benzyl)-4-(β-D-glucopyranos1-yl)-benzene,
- (5) 1-Chloro-2-[4-(1-tert-butyloxycarbonylpiperidin-4-yloxy)-benzyl]-4-(β-D-glucopyranos-1-yl)-benzene,
- (6) 1-Chloro-2-[4-(piperdin-4-yloxy)-benzyl]-4-(β-D-glucopyranos1-yl)-benzene,
- (7) 1-Methoxy-2-(β-D-glucopyranos1-yl)-4-(4-ethynyl-benzyl)-benzene,
- (8) 1-Chloro-2-(4-methoxymethylethynyl-benzyl)-4-(β-D-glucopyranos-1-yl)-benzene,
- (9) 1-Chloro-2-(4-hydroxymethylethynyl-benzyl)-4-(β-D-glucopyranos1-yl)-benzene,
- (10) 1-Chloro-2-(4-hydroxyethylethynyl-benzyl)-4-(β-D-glucopyranos1-yl)-benzene,
- (11) 1-Ethynyl-2-(4-methoxy-benzyl)-4-(β-D-glucopyranos1-yl)-benzene,
- (12) 1-Methyl-2-(4-butyn-1-yl-benzyl)-4-(β-D-glucopyranos-1-yl)-benzene,
- (13) 1-Chloro-2-(4-propyn1-yl-benzyl)-4-(β-D-glucopyranos-1-yl)-benzene,
- (14) 1-Methyl-2-(4-propyn1-yl-benzyl)-4-(β-D-glucopyranos-1-yl)-benzene,
- (15) 1-Isopropyl-2-(4-ethynyl-benzyl)-4-(β-D-glucopyranos-1-yl)-benzene,
- (16) 1-Chloro-2-(4-isopropylethynyl-benzyl)-4-(β-D-glucopyranos-1-yl)-benzene,
- or a derivative thereof wherein one or more hydroxyl groups of the β-D-glucopyranosyl group are acylated with groups selected from (C1-18-alkyl)carbonyl, (C1-18-alkyl)oxycarbonyl, phenylcarbonyl and phenyl-(C1-3-alkyl)-carbonyl, or a pharmaceutically acceptable salt thereof;
- including the tautomers, the stereoisomers thereof or the mixtures thereof, and salts thereof.
15 more elements
Dependencies are inferred from the claim text.